Supplemental Figure 1

1
Supplemental Figure 1 Minutes 2 4 6 8 10 12 14 16 18 20 22 24 m AU -3 -2 -1 0 1 2 3 4 5 m AU -3 -2 -1 0 1 2 3 4 5 EFV 245 21.494 6947 0.3125 CAL SpectraFOCUS-245nm S4 Name Retention Time A re a E S TD concentration SpectraFOCUS-245nm S10

description

Supplemental Figure 1. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 1

Page 1: Supplemental Figure 1

Supplemental Figure 1

Minutes

2 4 6 8 10 12 14 16 18 20 22 24

mAU

-3

-2

-1

0

1

2

3

4

5

mAU

-3

-2

-1

0

1

2

3

4

5

EFV

245

21

.494

69

47

0.31

25 C

AL

SpectraFOCUS-245nmS4

NameRetention TimeAreaESTD concentration

SpectraFOCUS-245nmS10

Supplemental Figure 1.

Supplemental Figure 1.

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

List of Supplemental Digital Content Supplemental Figure 1 ...

List of Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Figure 1 - Genes & Developmentgenesdev.cshlp.org/content/suppl/2013/11/01/27.21... · Supplemental Figure 1 Supplemental Fig. 1. (A) The binding avidity between Fz4-FcH6

Supplemental Figure 1 - Genes & Developmentgenesdev.cshlp.org/content/suppl/2013/11/01/27.21... · Supplemental Figure 1 Supplemental Fig. 1. (A) The binding avidity between Fz4-FcH6

Supplemental Figure 1.

Supplemental Figure 1.

Supplemental Figure Legends: Supplemental Figure 1 ...dm5migu4zj3pb.cloudfront.net/manuscripts/59000/59743/JCI...31 Supplemental Figure Legends: Supplemental Figure 1. Caerulein treatment

Supplemental Figure Legends: Supplemental Figure 1 ...dm5migu4zj3pb.cloudfront.net/manuscripts/59000/59743/JCI...31 Supplemental Figure Legends: Supplemental Figure 1. Caerulein treatment

Supplemental Figure 1

Supplemental Figure 1

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Figure legends: Supplemental Figure 1 A) TAA;

Figure legends: Supplemental Figure 1 A) TAA;

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental data: Supplemental Figure 1. Sequence of ...

Supplemental data: Supplemental Figure 1. Sequence of ...

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

Supplemental Figure 7(1) p u t SUPPLEMENTAL FIGURE 2 A B H3K4me3 loci Title Supplemental Figure 7(1).ai Created Date 20161030123200Z ...

Supplemental Figure 7(1) p u t SUPPLEMENTAL FIGURE 2 A B H3K4me3 loci Title Supplemental Figure 7(1).ai Created Date 20161030123200Z ...

BolteusBordey Supplemental Figure 1

BolteusBordey Supplemental Figure 1

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Supplemental Figure 1

Supplemental Figure 1